Patents by Inventor Dean Michaels

Dean Michaels has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240142351
    Abstract: An apparatus including: a housing configured for installation in a landfill; a differential pressure sensor and at least one gas sensor in the housing; and a first valve configured to control landfill gas (LFG) flow to the at least one gas sensor, wherein the first valve is configured to open when the differential pressure sensor detects a selected pressure difference or pressure difference change between the atmospheric air pressure and the LFG pressure.
    Type: Application
    Filed: February 22, 2022
    Publication date: May 2, 2024
    Inventors: Jonathan Glen Miller, Daniel Shane Egan, Abbas Zahedi Kouzani, Scott Daryl Adams, Dean Michael Corva, Nathan Ian Semianiw, Tianhao Wu, Matthew Zampatti
  • Patent number: 11972417
    Abstract: An encrypted payment message is received from a buyer relating to a transaction with a merchant. The payment message is parsed using a first parsing algorithm to obtain merchant identifying information. The merchant identifying information is associated with at least a second parsing algorithm or at least one settlement algorithm. The payment message is parsed using the second parsing algorithm to obtain payment information for the transaction. A first settlement algorithm is applied to the payment information to determine an adjusted interchange rate. The payment information including the adjusted interchange rate is submitted to a third party settlement processor on behalf of the merchant, using a payment algorithm. A second settlement algorithm applied to the payment information determines a buyer rebate which can be submitted to the settlement processor. A transaction result is reported to at least one of the merchant or the buyer.
    Type: Grant
    Filed: November 21, 2022
    Date of Patent: April 30, 2024
    Assignee: Boost Payment Solutions, Inc.
    Inventors: Dean Michael Leavitt, James Edward Lister
  • Patent number: 11964989
    Abstract: Compounds that inhibit KRas G12D. In particular, compounds that inhibit the activity of KRas G12D, pharmaceutical compositions comprising the compounds and methods of use therefor, and in particular, methods of treating cancer. The compounds have a general structure represented by Formula (I): or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: July 20, 2022
    Date of Patent: April 23, 2024
    Assignees: Mirati Therapeutics, Inc., Array BioPharma Inc.
    Inventors: Xiaolun Wang, Aaron Craig Burns, James Gail Christensen, John Michael Ketcham, John David Lawson, Matthew Arnold Marx, Christopher Ronald Smith, Shelley Allen, James F. Blake, Mark Joseph Chicarelli, Joshua Ryan Dahlke, Donghua Dai, Jay Bradford Fell, John Peter Fischer, Macedonio J. Mejia, Brad Newhouse, Phong Nguyen, Jacob Matthew O'Leary, Spencer Pajk, Martha E. Rodriguez, Pavel Savechenkov, Tony P. Tang, Guy P.A. Vigers, Qian Zhao, Dean Russell Kahn, John Gaudino, Michael Christopher Hilton
  • Patent number: 11952408
    Abstract: Provided are binding molecules, such as TCRs or antigen binding fragments thereof and antibodies and antigen-binding fragments thereof, such as those that recognize or bind human papilloma virus (HPV) 16, including HPV 16 E6 and HPV 16 E7. Also provided are engineered cells containing such binding molecules, compositions containing the binding molecules or engineered cells, and methods of treatment, such as administration of the binding molecules, engineered cells, or compositions.
    Type: Grant
    Filed: September 28, 2018
    Date of Patent: April 9, 2024
    Assignees: Juno Therapeutics, Inc., Editas Medicine, Inc.
    Inventors: Cameron Brandt, Brian Belmont, Christopher Borges, Stephen Michael Burleigh, Alexandra Croft, Stephen Jacob Goldfless, David Jeffrey Huss, Yue Jiang, Timothy G. Johnstone, David Koppstein, Hieu Nguyen, Christopher Heath Nye, Haley Peper, Blythe D. Sather, Sonia Timberlake, Dean Y. Toy, Queenie Vong, Gordon Grant Welstead, James Sissons
  • Patent number: 11944440
    Abstract: An implantable device for estimating neural recruitment arising from a stimulus, has a plurality of electrodes. A stimulus source provides stimuli to be delivered from the electrodes to neural tissue. Measurement circuitry obtains a measurement of a neural signal sensed at the electrodes. A control unit is configured to control application of a selected stimulus to neural tissue using the stimulus electrodes; and after the selected neural stimulus, apply a probe stimulus having a short pulse width. A remnant neural response evoked by the probe stimulus is measured; and the control unit estimates from the remnant neural response a neural recruitment caused by the selected neural stimulus.
    Type: Grant
    Filed: August 22, 2022
    Date of Patent: April 2, 2024
    Assignee: Saluda Medical Pty Ltd
    Inventors: John Louis Parker, James Hamilton Wah, Dean Michael Karantonis, Peter Scott Vallack Single
  • Patent number: 11939248
    Abstract: A system and method using a subterranean biological reactor can include a pre-reactor storage unit configured to receive a feedstock including a slurry of biologically derived material and at least one pump configured to pump the effluent from the pre-reactor storage unit. The system may include at least one wellbore containing a subterranean biological reactor configured to receive the effluent from the pre-reactor storage unit. At least a portion of the subterranean biological reactor may be configured to perform anaerobic digestion upon the effluent to generate a biogas.
    Type: Grant
    Filed: April 10, 2023
    Date of Patent: March 26, 2024
    Assignee: Schlumberger Technology Corporation
    Inventors: Dean Michael Willberg, Andrew Pomerantz, Thorarinn Kristjansson
  • Patent number: 11927773
    Abstract: A liquid lens comprising: a lens body including a cavity, a control electrode, and a common electrode; a first liquid disposed within the cavity and in electrical communication with the common electrode; a second liquid disposed within the cavity; an insulating layer in contact with the first liquid and the second liquid and separating the first liquid and the second liquid from the control electrode; and a driver driving a voltage differential across the common electrode and the control electrode, with the first liquid resisting current flow between the common electrode and the control electrode and thereby raising a temperature of the first liquid from a current temperature to a predetermined temperature, which is higher than the current temperature. The driver raises the temperature of the first liquid from the current temperature to the predetermined temperature by increasing a frequency of a voltage waveform of the voltage differential.
    Type: Grant
    Filed: March 19, 2019
    Date of Patent: March 12, 2024
    Assignee: CORNING INCORPORATED
    Inventors: Ian Armour McKay, Dragan Pikula, Dean Michael Thelen
  • Patent number: 11890113
    Abstract: A method for processing a neural measurement obtained in the presence of artifact, in order to detect whether a neural response is present in the neural measurement. A neural measurement is obtained from one or more sense electrodes. The neural measurement is correlated against a filter template, the filter template comprising at least three half cycles of an alternating waveform, amplitude modulated by a window. From an output of the correlating, it is determined whether a neural response is present in the neural measurement.
    Type: Grant
    Filed: April 8, 2022
    Date of Patent: February 6, 2024
    Assignee: Saluda Medical Pty Ltd
    Inventors: Peter Scott Vallack Single, Dean Michael Karantonis
  • Publication number: 20240033522
    Abstract: Recording evoked neural responses comprises delivering a stimulus from one or more stimulus electrodes to a neural pathway in order to give rise to an evoked compound action potential (ECAP) on the neural pathway. And, recording with measurement circuitry, during delivery of at least part of the stimulus, a neural compound action potential signal sensed at one or more sense electrodes. And, processing the recording of the neural compound action potential signal to determine at least one characteristic of the ECAP. At least one characteristic of the stimulus is then defined based on the determined at least one characteristic of the ECAP.
    Type: Application
    Filed: February 9, 2022
    Publication date: February 1, 2024
    Applicant: Saluda Medical Pty Ltd
    Inventors: Dean Michael Karantonis, Peter Scott Vallack Single, James Hamilton Wah
  • Publication number: 20240024683
    Abstract: Disclosed is a neurostimulation system comprising: a neuromodulation device for controllably delivering neural stimuli; a headset configured to be worn by the patient and to display images of a virtual object to the patient; one or more sensors configured to perceive a gesture of the patient; and an external computing device. The neuromodulation device comprises: a plurality of implantable electrodes; a stimulus source configured to deliver neural stimuli via selected ones of the implantable electrodes to a neural pathway of a patient; and a control unit configured to control the stimulus source to deliver each neural stimulus according to one or more stimulus parameters. The external computing device comprises a processor in communication with the neuromodulation device, the headset, and the one or more sensors.
    Type: Application
    Filed: July 21, 2023
    Publication date: January 25, 2024
    Applicant: Saluda Medical Pty Ltd
    Inventors: John Louis Parker, Dean Michael Karantonis, Matthew Marlon Williams, Samuel Nicholas Gilbert
  • Publication number: 20240017072
    Abstract: An implantable device comprising: stimulus electrodes and measurement electrodes; a stimulus source to provide a neural stimulus to be delivered to a neural pathway of a patient to evoke a neural response; measurement circuitry configured to capture a signal window sensed on the neural pathway; and a control unit configured to implement closed-loop neurostimulation therapy by: controlling the stimulus source to provide the neural stimulus according to a stimulus intensity parameter; measuring a characteristic of the signal window; computing a feedback variable from an intensity of an evoked neural response in the signal window; adjusting the stimulus intensity parameter using the feedback variable; and repeating the controlling, measuring, computing, and adjusting to maintain the feedback variable at a target, thereby obtaining multiple measured intensities of neural responses; and computing one or more quantitative indicators of efficacy of the closed-loop neurostimulation therapy using the measured characte
    Type: Application
    Filed: July 13, 2023
    Publication date: January 18, 2024
    Applicant: Saluda Medical Pty Ltd
    Inventors: John Louis Parker, Matthew Marlon Williams, Daniel John Parker, Dean Michael Karantonis, Samuel Nicholas Gilbert
  • Publication number: 20240000367
    Abstract: A method for determining a desired location at which to apply a neural therapy. An array of electrodes is positioned proximal to neural tissue. A stimulus is applied from the array which evokes a neural compound action potential response in the neural tissue proximal to the array. A plurality of electrodes of the array simultaneously obtain respective measurements of the neural compound action potential response. From the measurements of the neural compound action potential response a desired location for a neural therapy is determined.
    Type: Application
    Filed: September 14, 2023
    Publication date: January 4, 2024
    Applicant: Saluda Medical Pty Ltd
    Inventors: John Louis Parker, Dean Michael Karantonis
  • Publication number: 20240000358
    Abstract: An implantable device for estimating neural recruitment arising from a stimulus, has a plurality of electrodes. A stimulus source provides stimuli to be delivered from the electrodes to neural tissue. Measurement circuitry obtains a measurement of a neural signal sensed at the electrodes. A control unit is configured to control application of a selected stimulus to neural tissue using the stimulus electrodes; and after the selected neural stimulus, apply a probe stimulus having a short pulse width. A remnant neural response evoked by the probe stimulus is measured; and the control unit estimates from the remnant neural response a neural recruitment caused by the selected neural stimulus.
    Type: Application
    Filed: August 22, 2022
    Publication date: January 4, 2024
    Inventors: John Louis PARKER, James Hamilton WAH, Dean Michael KARANTONIS, Peter Scott Vallack SINGLE
  • Patent number: 11826156
    Abstract: A neural stimulus comprises at least three stimulus components, each comprising at least one of a temporal stimulus phase and a spatial stimulus pole. A first stimulus component delivers a first charge which is unequal to a third charge delivered by a third stimulus component, and the first charge and third charge are selected so as to give rise to reduced artefact at recording electrodes. In turn this may be exploited to independently control a correlation delay of a vector detector and an artefact vector to be non-parallel or orthogonal.
    Type: Grant
    Filed: October 25, 2021
    Date of Patent: November 28, 2023
    Assignee: Saluda Medical Pty Ltd
    Inventors: Dean Michael Karantonis, Peter Scott Vallack Single, Kai Huang
  • Publication number: 20230374366
    Abstract: Composite cement compositions and slurries for treating a well following a water-based wellbore operation are provided and comprise cement comprising at least one of cement particles and cementitious material, water, and water swellable particulates that are embedded in the cement, derived from an elastomeric material, and present at a concentration of at least about 2% by weight of the cement but no more than about 30% by weight of the cement. Methods for treating a well drilled with a water-based drilling mud are provided and comprise pumping the composite cement compositions and slurries into the well and treating the well by allowing the composite cement compositions and slurries to set or cure after being pumped into the well.
    Type: Application
    Filed: May 18, 2022
    Publication date: November 23, 2023
    Inventors: Valerie Gisele Helene Lafitte, Dean Michael Willberg, Anatoly Medvedev
  • Patent number: 11819332
    Abstract: A method for determining a desired location at which to apply a neural therapy. An array of electrodes is positioned proximal to neural tissue. A stimulus is applied from the array which evokes a neural compound action potential response in the neural tissue proximal to the array. A plurality of electrodes of the array simultaneously obtain respective measurements of the neural compound action potential response. From the measurements of the neural compound action potential response a desired location for a neural therapy is determined.
    Type: Grant
    Filed: December 24, 2019
    Date of Patent: November 21, 2023
    Assignee: Saluda Medical Pty Ltd
    Inventors: John Louis Parker, Dean Michael Karantonis
  • Publication number: 20230355984
    Abstract: There is provided a method and implantable device for controlling a neural stimulus, the neural stimulus being defined by an artefact mitigation status. The method comprises generating a first neural stimulus for delivery to neural tissue, sensing a first signal subsequent to the first neural stimulus, generating a second neural stimulus for delivery to the neural tissue, and sensing a second signal subsequent to the second neural stimulus. The method further comprises determining an artefact mitigation measure (AMM) effect level based on the first sensed signal and the second sensed signal, and setting, in response to comparing the AMM effect level with an AMM effect threshold, the artefact mitigation status of a third neural stimulus to active.
    Type: Application
    Filed: May 9, 2023
    Publication date: November 9, 2023
    Applicant: Saluda Medical Pty Ltd
    Inventors: Peter Scott Vallack Single, Dean Michael Karantonis, Daniel John Parker, Samuel Nicholas Gilbert
  • Patent number: 11808128
    Abstract: Methods for initiating chemical reactions in a wellbore include delivering one or more reactive components via a carrier fluid to the wellbore. The one or more reactive components delivered to the wellbore are configured to enable one or more chemical reactions to occur. The one or more chemical reactions are carried out until a threshold volume of the one or more reactive components is delivered to the wellbore.
    Type: Grant
    Filed: March 22, 2021
    Date of Patent: November 7, 2023
    Assignee: SCHLUMBERGER TECHNOLOGY CORPORATION
    Inventors: Alhad Phatak, Garud Bindiganavale Sridhar, Douglas Pipchuk, Dmitriy Potapenko, Dean Michael Willberg, James Ernest Brown
  • Publication number: 20230330418
    Abstract: An implantable device for delivering closed-loop neural stimulation therapy. The device comprises: a plurality of electrodes; a stimulus source to provide neural stimuli via the electrodes to a neural pathway; measurement circuitry to process signals sensed at the electrodes; and a control unit. The control unit is configured to: control the stimulus source to provide a first neural stimulus according to a first stimulus parameter; measure an intensity of a neural response evoked by the first stimulus; compute a feedback variable from the neural response; adjust the first stimulus parameter; repeat the control, measure, compute and adjust to maintain the feedback variable at a target response intensity; control the stimulus source to provide, interleaved with the first neural stimuli, a plurality of second neural stimuli according to respective second stimulus parameters; and monitor the therapy by analysing the sensed signals subsequent to each second neural stimulus.
    Type: Application
    Filed: April 14, 2023
    Publication date: October 19, 2023
    Applicant: Saluda Medical Pty Ltd
    Inventors: Samuel Nicholas Gilbert, Daniel John Parker, Dean Michael Karantonis
  • Publication number: 20230321443
    Abstract: Disclosed is a method of computing a probability distribution of the suitability of measurement electrode configurations for a neuromodulation device. The method comprises: computing the probability distribution of suitability of measurement electrode configurations from: a predetermined stimulus program vector of the neuromodulation device; and prior patient data. Also disclosed is an automated method of setting a measurement electrode configuration for a neuromodulation device configured to deliver a neural stimulus to a neural pathway of a patient.
    Type: Application
    Filed: March 22, 2023
    Publication date: October 12, 2023
    Applicant: Saluda Medical Pty Ltd
    Inventors: Dean Michael Karantonis, Daniel John Parker, Ian Cameron Gould